Biogen (NASDAQ:BIIB) stock rocketed to a six-year high earlier this week on news that its therapy, aducanumab, was the first Alzheimer’s drug approved in nearly 20 years by the U.S. Food and Drug Administration (FDA). This is a huge deal, not only for …
See Original Article

Over the past few months, Bloomberg's Howard Wolfson has interviewed the major Democratic candidates to help voters get to know the people vying
See Original Article

… promised to deliver at least 1 billion extra doses of vaccines over the next year, according to the final communique obtained by Bloomberg News.
See Original Article

Eric DeLong, left, and Logan Isner, right, are the recipients of the 2021 Certified Management Accountant (CMA) Scholarship offered by the Institute of
See Original Article

Many investors are putting money into cryptocurrency in an effort to join the ranks of those who have gotten rich by trading in digital coins. And soon, you might have the option to invest in cryptocurrency not just for the near term, but for your retirement.
See Original Article